Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D for Prevention of Severe Dengue
NCT06071481Phase 2Unknown
- Sponsor
- Bangabandhu Sheikh Mujib Medical University
- Start
- Jun 2023
- Primary completion
- Dec 2023
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of vitamin d in dengue fever (3 arms), sponsored by Bangabandhu Sheikh Mujib Medical University. Primary endpoint: Proportion of mortality and progression to severe dengue at 8 days. Status: unknown.
02
Drugs
vitamin d
03
Conditions
dengue fever
Beyond the preview
Go deeper on NCT06071481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06071481.